DexCom (DXCM) Revenue — Quarter Ended Jun 30, 2025
DexCom reported higher revenue for the quarter, driven by continued demand. The company's top line grew both from the preceding quarter and from the same period a year earlier.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
DexCom reported higher revenue for the quarter, driven by continued demand. The company's top line grew both from the preceding quarter and from the same period a year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.2B
Revenue reported for this quarter.
Quarter-over-quarter
+11.7%
Change from the immediately preceding quarter.
Year-over-year
+15.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $994.2M | +2.0% |
| Dec 31, 2024 | $1.1B | +7.6% |
| Mar 31, 2025 | $1B | +12.5% |
| Jun 30, 2025 | $1.2B | +15.2% |
Revenue performance
Revenue increased sequentially and year-over-year, reflecting strong business momentum.
Quarterly comparison
Compared to the prior quarter, revenue improved. On an annual basis, the comparison with the same quarter last year also showed an increase.
What to watch
The sustainability of the upward revenue trajectory will be a focus.